Liturri A

ORCID: 0009-0005-3291-8910 · 1 paper in corpus
2025
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph18030371

Background: Identification of targetable biomarkers to improve early disease detection and overall patient outcomes is becoming an urgent need in clinical oncology. Ovarian cancer (OC) has one of the highest mortality rates among gynecologi…